Upon completion of the merger, the combined company will operate under the name Ayala Pharmaceuticals, Inc., and will continue to trade on the OTCQX under Ayala’s current ticker symbol (“ADXS”).
Ayala Pharmaceuticals and Biosight Enter into Definitive Merger Agreement
